Wednesday, June 10, 2026

Intelligence Β· INN directory

Pharmaceutical Drugs

Regulatory status, brand names, and pipeline context for BD, medical affairs, and competitive intelligence teams.

Drugs indexed 4,797
Companies 1,769
Pipeline programs 20,548

Quick answer

NovaPharmaNews tracks 4,797 pharmaceutical drugs by INN (International Nonproprietary Name), with US FDA approval status, brand names, originators, routes of administration, and links to pipeline programs and patents. Search by generic name or browse A–Z for competitive intelligence and medical affairs reference.

Showing page 124 of 200 Β· By data quality, then INN

  1. esomeprazole

    APO-ESOMEPRAZOLE Alphapharm Pty Ltd

    EMA: approved Β· TGA: approved

    A02BC05
  2. estetrol

    FYLREVY

    EMA: approved

    G03CA10
  3. etarfolatide

    FOLCEPRI

    EMA: application withdrawn

    V09
  4. etranacogene dezaparvovec

    HEMGENIX

    EMA: approved

    B02BD
  5. etrasimod

    VELSIPITY Pfizer Australia Pty Ltd

    EMA: approved Β· TGA: approved

    L04AE05
  6. etuvetidigene autotemcel

    WASKYRA

    EMA: approved

    B06
  7. ex vivo expanded autologous human corneal epithelial cells containing stem cells

    HOLOCLAR

    EMA: approved

    S01XA19
  8. exenatide

    BYDUREON

    EMA: approved Β· NMPA: clinical trials

    A10BJ01
  9. faldaprevir

    FALDAPREVIR BOEHRINGER INGELHEIM

    EMA: application withdrawn

    J05AE
  10. fampridine

    FAMPYRA

    EMA: approved

    N07XX07
  11. faricimab

    VABYSMO Hoffmann-La Roche

    EMA: approved Β· TGA: approved

    S01L
  12. fedratinib

    INREBIC Bristol-Myers Squibb Australia Pty Ltd

    EMA: approved Β· TGA: approved

    L01EJ02
  13. fesoterodine

    TOVIAZ

    EMA: approved

    G04BD11
  14. fidanacogene elaparvovec

    BEQVEZ (PREVIOUSLY DURVEQTIX)

    EMA: withdrawn

  15. filgotinib

    JYSELECA

    EMA: approved

    L04AF04
  16. florbetaben (18f)

    NEURACEQ

    EMA: approved

    V09AX06
  17. florbetapir (18f)

    AMYVID

    EMA: approved

    V09AX05
  18. flortaucipir (18f)

    TAUVID

    EMA: approved Β· PMDA: approved

    V09AX07
  19. fluciclovine (18f)

    AXUMIN

    EMA: approved

    V09IX12
  20. flutemetamol (18f)

    VIZAMYL

    EMA: approved

    V09AX04
  21. follitropin alfa

    BEMFOLA Merck KGaA, Darmstadt, Germany

    EMA: approved Β· TGA: approved

    G03GA05
  22. follitropin beta

    PUREGON 300 IU/0.36 ML Organon Pharma Pty Ltd

    EMA: approved Β· TGA: approved

    G03GA06
  23. follitropin delta

    REKOVELLE Ferring Pharmaceuticals

    EMA: approved Β· TGA: approved

    G03GA10
  24. fomivirsen

    VITRAVENE

    EMA: withdrawn

    S01AD08

Frequently asked questions

What is the NovaPharmaNews drugs directory?

It is a searchable index of 4,797 pharmaceutical active ingredients and their marketed profiles β€” INN, brand names, US regulatory status, manufacturers, and cross-links to clinical pipeline and patent records.

Where does drug approval data come from?

Profiles combine FDA Drugs@FDA and Orange Book references, ClinicalTrials.gov pipeline links, and editorial enrichment. See our data sources page for attribution and update cadence. This directory is for professional reference, not medical advice.

How do I find a drug by brand name?

Use the search box on this page β€” it matches both INN (generic name) and slug. Brand names appear on each drug row and on the full drug profile page, with links to the originator company when available.